Edition:
United Kingdom

TapImmune Inc (TPIV.OQ)

TPIV.OQ on NASDAQ Stock Exchange Capital Market

2.91USD
20 Apr 2018
Change (% chg)

-- (--)
Prev Close
$2.91
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
10,223
52-wk High
$4.50
52-wk Low
$2.62

Chart for

About

TapImmune Inc. is an immuno-oncology company. The Company specializes in the development of peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer. The Company is engaged in developing vaccines that target candidate breast cancers, colorectal cancers, ovarian cancers and non-small cell lung cancers.... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): --
Shares Outstanding(Mil.): 10.16
Dividend: --
Yield (%): --

Financials

  TPIV.OQ Industry Sector
P/E (TTM): -- 84.02 32.74
EPS (TTM): -- -- --
ROI: -911.19 1.58 14.38
ROE: -911.19 2.41 16.07

BRIEF-Iroquois Capital Management LLC Reports A 5.5 Pct Stake In TapImmune As Of April 4

* IROQUOIS CAPITAL MANAGEMENT LLC REPORTS A 5.5 PCT STAKE IN TAPIMMUNE AS OF APRIL 4 - SEC FILING

04 Apr 2018

BRIEF-Tapimmune Q3 loss earnings per share $0.39‍​

* Tapimmune provides third quarter 2017 corporate and clinical update

15 Nov 2017

Earnings vs. Estimates

No consensus analysis data available.